Discontinued — last reported Q3 '25
Medline, Inc. New Operating Lease ROU remained flat by 0.0% to $28.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 19.6%, from $35.75M to $28.75M. Over 2 years (FY 2023 to FY 2025), New Operating Lease ROU shows a downward trend with a -10.9% CAGR.
An increase signals expansion of physical footprint or infrastructure capacity through leasing rather than capital expenditure.
Captures the non-cash impact of recognizing new right-of-use assets and corresponding lease liabilities under accounting...
Standard disclosure under ASC 842 for companies with significant real estate or equipment lease portfolios.
amzn_rou_asset_operating_lease_noncash| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $145.00M | $143.00M | $115.00M |
| YoY Change | — | -1.4% | -19.6% |